Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity

PET/CT is used to evaluate relapsed/refractory non-Hodgkin lymphoma (NHL) prior to chimeric antigen receptor T-cell (CAR-T) infusion at two time points: pre-leukapheresis (pre-leuk) and pre-lymphodepletion chemotherapy (pre-LD). We hypothesized that changes in PET/CT between these time points predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Breen, William G., Young, Jason R., Hathcock, Matthew A., Kowalchuk, Roman O., Thorpe, Matthew P., Bansal, Radhika, Khurana, Arushi, Bennani, N. Nora, Paludo, Jonas, Bisneto, Jose Villasboas, Wang, Yucai, Ansell, Stephen M., Peterson, Jennifer L., Johnston, Patrick B., Lester, Scott C., Lin, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435575/
https://www.ncbi.nlm.nih.gov/pubmed/37591834
http://dx.doi.org/10.1038/s41408-023-00895-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435575/
https://www.ncbi.nlm.nih.gov/pubmed/37591834
http://dx.doi.org/10.1038/s41408-023-00895-7

Ejemplares similares